This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 97/3/210    most recent 01.RES.0000176028.18423.07v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kaneda, R. Articles by Mano, H. Search for Related Content PubMed PubMed Citation Articles by Kaneda, R. Articles by Mano, H. Related Collections Functional genomics Gene expression Gene regulation Genomics

(Circulation Research. 2005;97:210.)
© 2005 American Heart Association, Inc.

Molecular Medicine

Genome-Wide Screening for Target Regions of Histone Deacetylases in Cardiomyocytes

Ruri Kaneda, Shuichi Ueno, Yoshihiro Yamashita, Young Lim Choi, Koji Koinuma, Shuji Takada, Tomoaki Wada, Kazuyuki Shimada, Hiroyuki Mano

From the Divisions of Functional Genomics (R.K., S.U., Y.Y., Y.L.C., K.K., S.T., T.W., H.M.) and Cardiovascular Medicine (R.K., S.U., K.S.), Jichi Medical School, Tochigi, Japan; and CREST (H.M.), Japan Science and Technology Agency, Saitama.

Correspondence to Dr Hiroyuki Mano, Division of Functional Genomics, Jichi Medical School, 3311-1 Yakushiji, Kawachigun, Tochigi 329-0498, Japan. E-mail hmano{at}jichi.ac.jp

The acetylation status of core histones in cardiomyocytes has been linked to the development of cardiac hypertrophy and heart failure. Little is known, however, of the genes affected by abnormal histone acetylation in such pathological conditions. We recently developed a genome-wide screening method, differential chromatin scanning (DCS), to isolate genomic fragments associated with histones subject to differential acetylation. We have now applied DCS to H9C2 rat embryonic cardiomyocytes incubated with or without trichostatin A (TSA), a specific inhibitor of histone deacetylase (HDAC) activity. About 200 genomic fragments were readily isolated by DCS on the basis of the preferential acetylation of associated histones in TSA-treated cells. Quantitation of the amount of DNA in chromatin immunoprecipitates prepared with antibodies to acetylated histone H3 revealed that 37 of 38 randomly chosen DCS clones were preferentially precipitated from the TSA-treated cells, thus verifying the high fidelity of DCS. Epigenetic regulation of DCS clones was further confirmed in cells treated with sodium butyrate, another HDAC inhibitor, as well as in cardiac myocytes isolated from neonatal rats. The mRNA level of 9 (39%) of 23 genes corresponding to DCS clones changed in parallel with the level of histone acetylation in H9C2 cells. Furthermore, a physiological hypertrophic stimulus, cardiotrophin-1, affected the acetylation level of histones associated with genomic regions corresponding to certain DCS clones. Our data thus establish a genome-wide profile of HDAC targets in cardiomyocytes, which should provide a basis for further investigations into the role of epigenetic modification in cardiac disorders.

Key Words: epigenetics • histone acetylation • trichostatin A • cardiomyocyte

This article has been cited by other articles:

				H. Zhang, A. Darwanto, T. A. Linkhart, L. C. Sowers, and L. Zhang Maternal Cocaine Administration Causes an Epigenetic Modification of Protein Kinase C{epsilon} Gene Expression in Fetal Rat Heart Mol. Pharmacol., May 1, 2007; 71(5): 1319 - 1328. [Abstract] [Full Text] [PDF]

				Y. Kong, P. Tannous, G. Lu, K. Berenji, B. A. Rothermel, E. N. Olson, and J. A. Hill Suppression of Class I and II Histone Deacetylases Blunts Pressure-Overload Cardiac Hypertrophy Circulation, June 6, 2006; 113(22): 2579 - 2588. [Abstract] [Full Text] [PDF]

				J. Backs and E. N. Olson Control of Cardiac Growth by Histone Acetylation/Deacetylation Circ. Res., January 6, 2006; 98(1): 15 - 24. [Abstract] [Full Text] [PDF]